SLN.L Share News (SLN)
SLN Share
SLN Share
SLN Share
SLN Share
SLN
SLN Share
SLN Broker
SLN Directors
SLN Financial
SLN
SLN Short
SLN
(Alliance News) - Silence therapeutics PLC said on Thursday that French investment bank Societe Generale SA has a 5% stake in the company.It was not disclosed how many shares, if any, that
Read moreLONDON (Alliance News) - Silence Therapeutics PLC said Monday that Steven Romano has joined as non-executive director, as part of the company's collaboration and equity investment by has USD5
Read more(Alliance News) - New York-listed Mallinckrodt PLC has invested USD5 million into Silence Therapeutics PLC, the two announced on Thursday, as part of a collaboration worth potentially hundreds of
Read moreWednesday 19 JuneTarsus GroupCadongan PetroleumWhitbreadSagaN4 20
Read more
(Sharecast News) - Novel therapeutics developer Silence Therapeutics has entered into a collaboration with Genomics England for the investigation of novel targets involved in human disease, it announced on Tuesday.
Read moreLONDON (Alliance News) - Silence Therapeutics PLC said Thursday it had reappointed Iain Ross as chair of the genetic medicines firm with immediate effect, alongside the hiring of another - who as
Read moreLONDON (Alliance News) - Silence Therapeutics PLC said on Thursday Interim Chief Financial Officer Rob Quinn has been promoted to the role on a permanent basis with immediate effect.He will
Read more(Sharecast News) - Biotechnology company Silence Therapeutics said it had appointed Rob Quinn to take over as its full-time chief financial officer, effective immediately.
Read moreLONDON (Alliance News) - Silence Therapeutics PLC on Tuesday reported a number of changes to its board and operational team, including its interim chair.Andy Richards has been serving as a
Read moreLONDON (Alliance News) - Silence Therapeutics PLC on Monday said its loss widened considerably in its most recent year after a gain on the disposal of its shares in Arrowhead Pharmaceuticals Inc a
Read more(Sharecast News) - Drug development company Silence Therapeutics announced its unaudited preliminary results for the year ended 31 December on Monday, reporting a loss after tax of £18.4m, widening form £1.6m a year earlier.
Read moreLONDON (Alliance News) - Silence Therapeutics on Tuesday said its SLN124 main candidate drug has been designated as an orphan drug in Europe for the treatment of beta-thalassemia.Shares in
Read more(Sharecast News) - Silence Therapeutics chief financial officer David Ellam stepped down from the group with immediate effect on Wednesday.
Read moreLONDON (Alliance News) - Silence Therapeutics PLC said Wednesday Chief Financial Officer David Ellam has resigned from the serious disease treatment firm with immediate effect.Ellam - CFO -
Read moreLONDON (Alliance News) - Silence Therapeutics PLC said Thursday the US Patent Trial & Appeal Board rejected Alnylam Pharmaceutics Inc's petition against newly-issued Silence filed a total
Read more